Literature DB >> 24105484

Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice.

Jonas Benzler1, Zane B Andrews, Corinna Pracht, Sigrid Stöhr, Peter R Shepherd, David R Grattan, Alexander Tups.   

Abstract

The WNT pathway has been well characterized in embryogenesis and tumorigenesis. In humans, specific polymorphisms in the T cell-specific transcription factor 7 and the WNT coreceptor, low-density lipoprotein receptor-related protein-6 (LRP-6), both prominent components of this pathway, correlate with a higher incidence of type 2 diabetes, suggesting that the WNT pathway might be involved in the control of adult glucose homeostasis. We previously demonstrated that glycogen-synthase-kinase-3β (GSK-3β), the key enzyme of the WNT pathway, is increased in the hypothalamus during obesity and exacerbates high-fat diet-induced weight gain as well as glucose intolerance. These data suggest that WNT action in the hypothalamus might be required for normal glucose homeostasis. Here we characterized whether WNT signaling in general is altered in the hypothalamus of adult obese mice relative to controls. First we identified expression of multiple components of this pathway in the murine arcuate nucleus by in situ hybridization. In this region mRNA of ligands and target genes of the WNT pathway were down-regulated in obese and glucose-intolerant leptin-deficient mice. Similarly, the number of cells immunoreactive for the phosphorylated (active) form of the WNT-coreceptor LRP-6 was also decreased in leptin-deficient mice. Leptin treatment normalized expression of the WNT-target genes Axin-2 and Cylin-D1 and increased the number of phospho-LRP-6-immunoreactive cells reaching levels of lean controls. Leptin also increased the levels of phosphorylated (inactive) GSK-3β in the arcuate nucleus, and this effect was colocalized to neuropeptide Y neurons, suggesting that inactivation of GSK-3β may contribute to the neuroendocrine control of energy homeostasis. Taken together our findings identify hypothalamic WNT signaling as an important novel pathway that integrates peripheral information of the body's energy status encoded by leptin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105484     DOI: 10.1210/en.2013-1746

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

Review 1.  New targets to treat obesity and the metabolic syndrome.

Authors:  Kathleen A Martin; Mitra V Mani; Arya Mani
Journal:  Eur J Pharmacol       Date:  2015-05-19       Impact factor: 4.432

2.  Hypothalamic leptin sensitivity and health benefits of time-restricted feeding are dependent on the time of day in male mice.

Authors:  Alisa Boucsein; Mohammed Z Rizwan; Alexander Tups
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

3.  Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis.

Authors:  Pedro Cisternas; Paulina Salazar; Carmen Silva-Álvarez; L Felipe Barros; Nibaldo C Inestrosa
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

Review 4.  Metabolic regulation and energy homeostasis through the primary Cilium.

Authors:  Edwin C Oh; Shivakumar Vasanth; Nicholas Katsanis
Journal:  Cell Metab       Date:  2014-12-24       Impact factor: 27.287

Review 5.  Molecular regulation of hypothalamic development and physiological functions.

Authors:  Yanxia Gao; Tao Sun
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

6.  Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1.

Authors:  Amanda T Mah; Laurianne Van Landeghem; Hannah E Gavin; Scott T Magness; P Kay Lund
Journal:  Endocrinology       Date:  2014-06-10       Impact factor: 4.736

Review 7.  WNT Signaling in Cardiac and Vascular Disease.

Authors:  Sébastien Foulquier; Evangelos P Daskalopoulos; Gentian Lluri; Kevin C M Hermans; Arjun Deb; W Matthijs Blankesteijn
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

Review 8.  The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome.

Authors:  Maen D Abou Ziki; Arya Mani
Journal:  Nutr Res       Date:  2018-07-04       Impact factor: 3.315

9.  Heart- and muscle-derived signaling system dependent on MED13 and Wingless controls obesity in Drosophila.

Authors:  Ji-Hoon Lee; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

Review 10.  Metabolic syndrome: genetic insights into disease pathogenesis.

Authors:  Maen D Abou Ziki; Arya Mani
Journal:  Curr Opin Lipidol       Date:  2016-04       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.